Table of Content

Executive Summary
Scope and Definition
Market/Product Definition
Inclusion and Exclusion
Key Questions Answered
Analysis and Forecast Note

1. Markets: Industry Outlook
1.1 Introduction
1.2 Market Trends
1.3 Regulatory Framework
1.4 Clinical Trial Analysis
1.5 Epidemiology Analysis
1.6 Market Dynamics
1.6.1 Impact Analysis
1.6.2 Market Drivers
1.6.3 Market Challenges
1.6.4 Market Opportunities

2. Global Alopecia Areata Market, by Drug Class, ($Million), 2023-2035
2.1 Corticosteroids
2.2 JAK (Janus Kinase) Inhibitors
2.3 Others

3. Global Alopecia Areata Market, by Region, ($Million), 2023-2035
3.1 North America
3.1.1 Key Findings
3.1.2 Market Dynamics
3.1.3 Market Sizing and Forecast
3.1.3.1 North America Alopecia Areata Market, by Country
3.1.3.1.1 U.S.
3.2 Europe
3.2.1 Key Findings
3.2.2 Market Dynamics
3.2.3 Market Sizing and Forecast
3.2.3.1 Europe Alopecia Areata Market, by Country
3.2.3.1.1 Germany
3.2.3.1.2 U.K.
3.2.3.1.3 France
3.2.3.1.4 Italy
3.2.3.1.5 Spain
3.3 Asia Pacific
3.3.1 Key Findings
3.3.2 Market Dynamics
3.3.3 Market Sizing and Forecast
3.3.3.1 Asia Pacific Alopecia Areata Market, by Country
3.3.3.1.1 Japan

4. Global Alopecia Areata Market: Competitive Landscape and Company Profiles
4.1 Key Developments and Strategies
4.1.1 Mergers and Acquisitions
4.1.2 Synergistic Activities
4.1.3 Business Expansions and Funding
4.1.4 Product Launches and Approvals
4.1.5 Other Activities
4.2 Company Profiles
4.2.1 Eli Lilly and Company
4.2.1.1 Overview
4.2.1.2 Top Products / Product Portfolio
4.2.1.3 Target Customers/End-Users
4.2.1.4 Key Personnel
4.2.1.5 Analyst View
4.2.2 Pfizer Inc
4.2.2.1 Overview
4.2.2.2 Top Products / Product Portfolio
4.2.2.3 Target Customers/End-Users
4.2.2.4 Key Personnel
4.2.2.5 Analyst View
4.2.3 Sun Pharmaceutical Industries Ltd
4.2.3.1 Overview
4.2.3.2 Top Products / Product Portfolio
4.2.3.3 Target Customers/End-Users
4.2.3.4 Key Personnel
4.2.3.5 Analyst View
4.2.4 Arcutis Biotherapeutics
4.2.4.1 Overview
4.2.4.2 Top Products / Product Portfolio
4.2.4.3 Target Customers/End-Users
4.2.4.4 Key Personnel
4.2.4.5 Analyst View
4.2.5 Bristol-Myers Squibb
4.2.5.1 Overview
4.2.5.2 Top Products / Product Portfolio
4.2.5.3 Target Customers/End-Users
4.2.5.4 Key Personnel
4.2.5.5 Analyst View
4.2.6 AbbVie
4.2.6.1 Overview
4.2.6.2 Top Products / Product Portfolio
4.2.6.3 Target Customers/End-Users
4.2.6.4 Key Personnel
4.2.6.5 Analyst View
4.2.7 Regeneron Pharmaceuticals
4.2.7.1 Overview
4.2.7.2 Top Products / Product Portfolio
4.2.7.3 Target Customers/End-Users
4.2.7.4 Key Personnel
4.2.7.5 Analyst View
4.2.8 Aclaris Therapeutics
4.2.8.1 Overview
4.2.8.2 Top Products / Product Portfolio
4.2.8.3 Target Customers/End-Users
4.2.8.4 Key Personnel
4.2.8.5 Analyst View

5. Research Methodology

List of Figures
Figure: Global Alopecia Areata Market (by Region), $Million, 2024 and 2035
Figure: Global Alopecia Areata Market Coverage
Figure: Global Alopecia Areata Market Key Trend Analysis

List of Tables
Table: Global Alopecia Areata Market Dynamics, Impact Analysis
Table: Global Alopecia Areata Market (by Drug Class), $Million, 2023-2035
Table: Global Alopecia Areata Market (by Region), $Million, 2023-2035